![Arie Mayer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 529 906 $ al 31/08/2026
Arie Mayer has been Chairman & Managing Director at Sigma-Aldrich Israel Ltd. since 2010, with employment at the firm starting in 1995.
Since 2019, Dr. Mayer has served as an Independent Director at Oramed Pharmaceuticals, Inc. Education includes a doctorate from Technion-Israel Institute of Technology and an undergraduate degree from The Hebrew University of Jerusalem.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/07/2026 | 105.559 ( 0,26 % ) | 529 906 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Director/Miembro de la Junta | 05/12/2019 |
Sigma-Aldrich Israel Ltd.
 Sigma-Aldrich Israel Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director Ejecutivo | 01/01/2010 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Technion-Israel Institute of Technology
 Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oramed Pharmaceuticals, Inc.
 Oramed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Sigma-Aldrich Israel Ltd.
Sigma-Aldrich Israel Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
